Growth Metrics

TransMedics (TMDX) Preferred Stock Liabilities (2018 - 2019)

TransMedics has reported Preferred Stock Liabilities over the past 2 years, most recently at $186.5 million for Q1 2019.

  • For Q1 2019, Preferred Stock Liabilities changed N/A year-over-year to $186.5 million; the TTM value through Mar 2019 reached $186.5 million, changed N/A, while the annual FY2018 figure was $186.5 million, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q1 2019 was $186.5 million at TransMedics, roughly flat from $186.5 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $186.5 million in Q4 2018 and troughed at $186.5 million in Q4 2018.